NEVVI Medicare utilization intelligence

← back

ROSS, MITCHELLMD NPI 1275995540 Clinician

Hematology-Oncology · FAYETTEVILLE, AR

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL) — medical school, self-reported to CMS
In practice about 10 years since medical school (class of 2016, self-reported to CMS)
Location FAYETTEVILLE, AR · NPPES registered location
Active in data Billed Medicare 2022–2024 (3 consecutive years)
Scale 118 codes billed · 170,437 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20232026
HIGHLANDS ONCOLOGY GROUP PA
2023–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2022-08

Year: 2024 · 2023 · 2022 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9299 Injection, nivolumab, 1 mg
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J1071 Injection, testosterone cypionate, 1 mg
A9575 Injection, gadoterate meglumine, 0.1 ml
J9271 Injection, pembrolizumab, 1 mg
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1453 Injection, fosaprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
J1437 Injection, ferric derisomaltose, 10 mg
J9041 Injection, bortezomib, 0.1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
83735 Magnesium level
84100 Phosphate level
83615 Lactate dehydrogenase (enzyme) level
84550 Uric acid level, blood
82248 Bilirubin level, direct
J2469 Injection, palonosetron hcl, 25 mcg
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9190 Injection, fluorouracil, 500 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3480 Injection, potassium chloride, per 2 meq
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
86140 Measurement c-reactive protein for detection of infection or inflammation
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
83521 Measurement of immunoglobulin light chains
J9045 Injection, carboplatin, 50 mg
71260 Ct scan of chest with contrast
96375 Injection of additional new drug or substance into vein
J3489 Injection, zoledronic acid, 1 mg
74178 Ct scan of abdomen and pelvis before and after contrast
A9573 Injection, gadopiclenol, 1 ml
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J7030 Infusion, normal saline solution , 1000 cc
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96360 Infusion into a vein for hydration, 31-60 minutes
J9060 Injection, cisplatin, powder or solution, 10 mg
84443 Blood test, thyroid stimulating hormone (tsh)
82784 Gammaglobulin (immune system protein) measurement
J3490 Unclassified drugs
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96415 Administration of chemotherapy into vein, each additional hour
36415 Insertion of needle into vein for collection of blood sample
82378 Carcinoembryonic antigen (cea) protein level
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
96417 Administration of additional new drug or substance into vein, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
82977 Glutamyltransferase (liver enzyme) level
82232 Beta-2 microglobulin (protein) level
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
82306 Vitamin d-3 level
84153 Psa (prostate specific antigen) measurement, total
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
84436 Thyroxine (thyroid chemical), total
85652 Red blood cell sedimentation rate, to detect inflammation, automated
J2250 Injection, midazolam hydrochloride, per 1 mg
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
96411 Administration of additional new drug or substance into vein using push technique
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
70553 Mri scan of brain before and after contrast
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
81003 Automated urinalysis test
82565 Blood creatinine level
70491 Ct scan of soft tissue of neck with contrast
78816 Nuclear medicine study whole body with ct scan
J1940 Injection, furosemide, up to 20 mg
99239 Hospital discharge day management, more than 30 minutes
82533 Cortisol (hormone) measurement, total
71046 X-ray of chest, 2 views
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
81001 Manual urinalysis test with examination using microscope, automated
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96416 Administration of prolonged chemotherapy into vein
96523 Irrigation of implanted venous access drug delivery device
J2175 Injection, meperidine hydrochloride, per 100 mg
70470 Ct scan of head or brain before and after contrast
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
96361 Infusion into a vein for hydration, each additional hour
96374 Injection of drug or substance into vein
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
71250 Ct scan of chest without contrast
84439 Thyroxine (thyroid chemical), free
38222 Biopsy and aspiration of bone marrow sample for diagnosis
80400 Hormonal panel for adrenal gland assessment (adrenal gland insufficiency)
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
74183 Mri scan of abdomen before and after contrast
85045 Red blood count, automated test
90653 Influenza vaccine, inactivated
G0008 Administration of influenza virus vaccine
74176 Ct scan of abdomen and pelvis without contrast
78814 Nuclear medicine study limited area with ct scan
93356 Heart muscle strain imaging
93971 Ultrasound study of one arm or leg veins with compression and maneuvers

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.